Trial to Evaluate Efficacy of Pharmacogenetic Information Obtained With NEUROPHARMAGEN in Treatment of MDD Patients

Clinical trial NCT02529462 · COMPLETED

Trial details

NCT number: NCT02529462
Sponsor: AB Biotics, SA
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Depressive Disorder, Major

Start date: 2014-07-01
Primary completion: 2015-10-01
Enrollment: 521

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.